unknown
Stage
About
Huidagene is a biotechnology company developing gene therapies focusing on ophthalmology, neurology, and neuromuscular diseases using CRISPR and AAV platforms.
Explore Huidagene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.